MSB 1.04% $1.46 mesoblast limited

interesting read from CNBC website regarding Remdesivir ramping...

  1. 3,927 Posts.
    lightbulb Created with Sketch. 369
    interesting read from CNBC website regarding Remdesivir ramping up something like 1.5m doses, this is to treat patients with the most severe symptoms COVID-19.

    Their drug was ok'd in Europe for compassionate use in April 3.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.